This is the authors' abstract. We don't add key points for this paper.
Although the use of CAM by patients with cancer is high, patients frequently fail to disclose its use to their health professionals for reasons emanating from both sides of the dyadic patient-doctor relationship. Because a substantial proportion of patients with cancer may use CAM and there is potential for herb- or vitamin-drug interactions, further research in patient-doctor communication about CAM is necessary to maintain patient safety and wellbeing. The development of effective interventions to improve the disclosure of CAM use should be an integral part of this future research.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Davis et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: